These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Supplemented vaccination with tandem repeat M2e virus-like particles enhances protection against homologous and heterologous HPAI H5 viruses in chickens. Song BM, Kang HM, Lee EK, Jung SC, Kim MC, Lee YN, Kang SM, Lee YJ. Vaccine; 2016 Jan 27; 34(5):678-686. PubMed ID: 26691568 [Abstract] [Full Text] [Related]
3. Protective efficacy of baculovirus-derived influenza virus-like particles bearing H5 HA alone or in combination with M1 in chickens. Choi JG, Kim MC, Kang HM, Kim KI, Lee KJ, Park CK, Kwon JH, Kim JH, Lee YJ. Vet Microbiol; 2013 Mar 23; 162(2-4):623-630. PubMed ID: 23265240 [Abstract] [Full Text] [Related]
4. Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens. Pushko P, Tretyakova I, Hidajat R, Zsak A, Chrzastek K, Tumpey TM, Kapczynski DR. Virology; 2017 Jan 15; 501():176-182. PubMed ID: 27936463 [Abstract] [Full Text] [Related]
6. Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China. Connie Leung YH, Luk G, Sia SF, Wu YO, Ho CK, Chow KC, Tang SC, Guan Y, Malik Peiris JS. Vaccine; 2013 Aug 02; 31(35):3536-42. PubMed ID: 23791547 [Abstract] [Full Text] [Related]
8. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens. Jadhao SJ, Lee CW, Sylte M, Suarez DL. Vaccine; 2009 Oct 19; 27(44):6247-60. PubMed ID: 19686695 [Abstract] [Full Text] [Related]
9. Incorporation of conserved nucleoprotein into influenza virus-like particles could provoke a broad protective immune response in BALB/c mice and chickens. Xue C, Tian G, Chen X, Liu Q, Ma J, Xu S, Li X, Chen H, Cao Y. Virus Res; 2015 Jan 02; 195():35-42. PubMed ID: 25312452 [Abstract] [Full Text] [Related]
11. Potency of a recombinant NDV-H5 vaccine against various HPAI H5N1 virus challenges in SPF chickens. Lardinois A, Steensels M, Lambrecht B, Desloges N, Rahaus M, Rebeski D, van den Berg T. Avian Dis; 2012 Dec 02; 56(4 Suppl):928-36. PubMed ID: 23402114 [Abstract] [Full Text] [Related]
13. Efficacy of a recombinant HVT-H5 vaccine against challenge with two genetically divergent Indonesian HPAI H5N1 strains. Soejoedono RD, Murtini S, Palya V, Felföldi B, Mató T, Gardin Y. Avian Dis; 2012 Dec 02; 56(4 Suppl):923-7. PubMed ID: 23402113 [Abstract] [Full Text] [Related]
14. Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses. Kapczynski DR, Pantin-Jackwood MJ, Spackman E, Chrzastek K, Suarez DL, Swayne DE. Vaccine; 2017 Nov 01; 35(46):6345-6353. PubMed ID: 28456525 [Abstract] [Full Text] [Related]
15. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus. Kapczynski DR, Esaki M, Dorsey KM, Jiang H, Jackwood M, Moraes M, Gardin Y. Vaccine; 2015 Feb 25; 33(9):1197-205. PubMed ID: 25613723 [Abstract] [Full Text] [Related]